Skip to Main Content
Table I.

Patient characteristics

Patient/SexAgeOnsetaDisease Duration (years)Drugsb
1/F 21 poly+ 9.0 NSAIDs 
2/F 18 poly 15.0 NSAIDs 
3/F 16 poly+ 8.0 NSAIDs 
4/F 15 poly 12.0 NSAIDs, Gold 
5/M 14 poly+ 0.5 NSAIDs, MTX, HCLq 
6/F 15 poly+ 0.75 NSAIDs, MTX, HCLq 
7/M 14 systemic 2.0 NSAIDs, MTX, HCLq 
8/F 13 poly+ 4.0 NSAIDs 
9/F 12 pauci 10.0 NSAIDs 
10/F 07 poly 0.75 NSAIDs 
11/F 06 poly 0.83 NSAIDs 
12/F 05 poly 1.17 NSAIDs 
13/F 21 poly+ 16 NSAIDs, Gold 
14/F 18 poly+ NSAIDs, MTX, HCLq 
15/F 02 pauci 0.5 NSAIDs 
16/F 7.5 pauci 5.5 NSAIDs 
17/F 5.5 pauci 4.0 NSAIDs 
Patient/SexAgeOnsetaDisease Duration (years)Drugsb
1/F 21 poly+ 9.0 NSAIDs 
2/F 18 poly 15.0 NSAIDs 
3/F 16 poly+ 8.0 NSAIDs 
4/F 15 poly 12.0 NSAIDs, Gold 
5/M 14 poly+ 0.5 NSAIDs, MTX, HCLq 
6/F 15 poly+ 0.75 NSAIDs, MTX, HCLq 
7/M 14 systemic 2.0 NSAIDs, MTX, HCLq 
8/F 13 poly+ 4.0 NSAIDs 
9/F 12 pauci 10.0 NSAIDs 
10/F 07 poly 0.75 NSAIDs 
11/F 06 poly 0.83 NSAIDs 
12/F 05 poly 1.17 NSAIDs 
13/F 21 poly+ 16 NSAIDs, Gold 
14/F 18 poly+ NSAIDs, MTX, HCLq 
15/F 02 pauci 0.5 NSAIDs 
16/F 7.5 pauci 5.5 NSAIDs 
17/F 5.5 pauci 4.0 NSAIDs 
a

poly, polyarticular seronegative JRA; poly+, polyarticular seropositive JRA; pauci, pauciarticular JRA.

b

NSAID, nonsteroidal antiinflammatory drug; MTX, methotrexate; HCLq, hydroxychloroquine.

Close Modal

or Create an Account

Close Modal
Close Modal